Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam Brufsky

Showing results (71-80 of 193) with videos related to

Pageof 20
Sort By:
Clinical Breast Cancer|June 1, 2022
Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database AnalysisDebra Patt, Xianchen Liu, Benjamin Li, et al.
The Journal of Clinical Endocrinology and Metabolism|October 19, 2006
Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trialSusan L Greenspan, Rajib K Bhattacharya, Susan M Sereika, et al.
Archives of Pathology & Laboratory Medicine|November 9, 2006
Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 casesNicole Nicosia Esposito, Deepak Mohan, Adam Brufsky, et al.
Journal of Andrology|April 4, 2006
Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells?Stephen J Winters, Chenxi Wang, Eiman Abdelrahaman, et al.
Breast (Edinburgh, Scotland)|April 20, 2023
Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancerHope S Rugo, Xianchen Liu, Benjamin Li, et al.
European Journal of Breast Health|July 14, 2020
Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 TrialAtilla Soran, Serdar Özbaş, Lütfi Doğan, et al.
Cancer Causes & Control : CCC|November 1, 2011
Factors associated with mortality after breast cancer metastasisSu Yon Jung, Margaret Rosenzweig, Susan M Sereika, et al.
Breast Cancer Research and Treatment|July 9, 2011
The effect of delays in treatment for breast cancer metastasis on survivalSu Yon Jung, Susan M Sereika, Faina Linkov, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2011
Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancerSu Yon Jung, Margaret Rosenzweig, Faina Linkov, et al.
The Journal of Biological Chemistry|August 23, 2013
An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migrationBae-Hang Park, Sungho Kook, SeanBong Lee, et al.
Pageof 20

Showing results (71-80 of 193) with videos related to

Sort By:
Pageof 20
Clinical Breast Cancer|June 1, 2022
Real-World Treatment Patterns and Outcomes of Palbociclib Plus an Aromatase Inhibitor for Metastatic Breast Cancer: Flatiron Database AnalysisDebra Patt, Xianchen Liu, Benjamin Li, et al.
The Journal of Clinical Endocrinology and Metabolism|October 19, 2006
Prevention of bone loss in survivors of breast cancer: A randomized, double-blind, placebo-controlled clinical trialSusan L Greenspan, Rajib K Bhattacharya, Susan M Sereika, et al.
Archives of Pathology & Laboratory Medicine|November 9, 2006
Phyllodes tumor: a clinicopathologic and immunohistochemical study of 30 casesNicole Nicosia Esposito, Deepak Mohan, Adam Brufsky, et al.
Journal of Andrology|April 4, 2006
Inhibin-B levels in healthy young adult men and prepubertal boys: is obesity the cause for the contemporary decline in sperm count because of fewer Sertoli cells?Stephen J Winters, Chenxi Wang, Eiman Abdelrahaman, et al.
Breast (Edinburgh, Scotland)|April 20, 2023
Real-world comparative effectiveness of palbociclib plus letrozole versus letrozole in older patients with metastatic breast cancerHope S Rugo, Xianchen Liu, Benjamin Li, et al.
European Journal of Breast Health|July 14, 2020
Loco-Regional Treatment for Intact Primary Tumor in Patient with De Novo Metastatic Breast Cancer; Comments and Concerns of ECOG-ACRIN 2108 TrialAtilla Soran, Serdar Özbaş, Lütfi Doğan, et al.
Cancer Causes & Control : CCC|November 1, 2011
Factors associated with mortality after breast cancer metastasisSu Yon Jung, Margaret Rosenzweig, Susan M Sereika, et al.
Breast Cancer Research and Treatment|July 9, 2011
The effect of delays in treatment for breast cancer metastasis on survivalSu Yon Jung, Susan M Sereika, Faina Linkov, et al.
Hypertension (Dallas, Tex. : 1979)|December 21, 2011
Comorbidity as a mediator of survival disparity between younger and older women diagnosed with metastatic breast cancerSu Yon Jung, Margaret Rosenzweig, Faina Linkov, et al.
The Journal of Biological Chemistry|August 23, 2013
An isoform of C/EBPβ, LIP, regulates expression of the chemokine receptor CXCR4 and modulates breast cancer cell migrationBae-Hang Park, Sungho Kook, SeanBong Lee, et al.
Pageof 20